- Investing Ideas
- /
- Chinese Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Chinese Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
9
High return on equity, past performance and sound balance sheet.
9 companies
Xiamen Amoytop Biotech
Market Cap: CN¥29.9b
Engages in research, development, production, and sale of recombinant protein drugs in China.
688278
CN¥73.56
7D
-4.8%
1Y
39.8%
Henan Lingrui Pharmaceutical
Market Cap: CN¥13.6b
Produces and sells medicines in China.
600285
CN¥24.17
7D
1.8%
1Y
-2.7%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥43.2b
Shanghai Allist Pharmaceuticals Co., Ltd.
688578
CN¥96.00
7D
-2.0%
1Y
55.1%
Imeik Technology DevelopmentLtd
Market Cap: CN¥52.8b
Engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China.
300896
CN¥175.15
7D
3.0%
1Y
-12.4%
Shandong Wit Dyne HealthLtd
Market Cap: CN¥7.5b
Engages in the pharmaceutical business in China.
000915
CN¥32.00
7D
3.4%
1Y
-1.5%
WuXi AppTec
Market Cap: CN¥186.2b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥64.80
7D
2.0%
1Y
52.9%
Tianjin Pharmaceutical Da Ren Tang Group
Market Cap: CN¥23.3b
Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China.
600329
CN¥34.65
7D
2.0%
1Y
-5.8%
Sichuan Biokin PharmaceuticalLtd
Market Cap: CN¥132.9b
Engages in the research and development, production, and marketing of small molecule chemical, macromolecular biological, and antibody-drug conjugate drugs in China and internationally.
688506
CN¥331.48
7D
10.1%
1Y
60.2%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥13.6b
Engages in the research and development, production, and sale of ophthalmic drug in the People’s Republic of China.
300573
CN¥55.59
7D
6.6%
1Y
-58.3%